CONNECT Cancer Survivors With Tobacco Treatment
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Jun 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Cancer Prevention by Reducing Tobacco Trial is studying how to help people stop using tobacco and improve their chances of quitting smoking. The trial will compare two different methods: one that uses reminders and encouragement (called nudges) to motivate people to change their tobacco use, and another that focuses on traditional quit methods, like medications and counseling. The goal is to find out which approach is more effective in helping people quit smoking and reduce their risk of cancer.
To take part in this trial, you need to be at least 18 years old, currently using tobacco, and receiving care at a clinic that is part of the study. If you join, you can expect to receive support and resources aimed at helping you quit smoking. This trial is not yet recruiting participants, but it aims to gather important information that could help many people improve their health by quitting tobacco.
Gender
ALL
Eligibility criteria
- Eligibility Criteria:
- • Be receiving care at a participating clinic
- • Report current tobacco use (assessed by the rooming staff during the index visit)
- • Have a completed appointment with a participating clinic
- • Be an adult (at least 18 years old).
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Li-Shiun Chen, M.D., MPH, ScD
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported